Bio&TechWebinar

Follow us, we'll keep you updated #Research #Lifescience #Biotech #Medtech #Pharma #Microbiology #Cancer #Oncology

[NEJM @NEJM]

Evidence is accumulating that eating in a 6-hour period and fasting for 18 hours can trigger a metabolic switch from glucose-based to ketone-based energy. https://t.co/AkSEMPUpWw

[Hakim @hakim034]

When you tried 3 times to clone that little peace of DNA whithout success and then decide to go boldly #phdlife #Science #scicomm At least it's in.

[Matthew Herper @matthewherper]

To people in the drug industry, it's clear nobody should have believed that "complete cancer cure" story. So why did it go viral? https://t.co/Vli9OfCCOb

[Genetic Engineering & Biotechnology News @GENbio]

Scientists find a method to block the VCC-1 enzyme, which disables the VCC-1 antimicrobial-resistance gene: https://t.co/qam61AoCx4

[Eric Topol @EricTopol]

A big day for #CRISPR genome editing in models of Duchenne muscular dystrophy and Progeria: 1-time dosing, long-term effect, marching towards curative potential
@NatureMedicine @cgersbach @DukeU @salkinstitute @uniovi_info
https://t.co/vi4Gakyriv

[Endpoints News @endpts]

#FDA doc reveals agency charged Immunomedics with data integrity breach after August plant inspection https://t.co/qkpTGWEAi9

[CNRS Chimie @CNRSchimie]

Des scientifiques de @IMN44 à la recherche de nouveaux matériaux pour le stockage de l'énergie #anneedelachimie #energie
➡️ https://t.co/uY06YCIXHS
🤝 @CNRS_dr17

[Bio&TechWebinar @BioTechWebinar]

$PFE hits the gas pedal in the mRNA flu #vaccine development race, inking a $425M investment pact with BioNTech #pharma #biotech https://t.co/QomFWDGxBn

[STAT @statnews]

BREAKING: FDA approves first-ever RNAi-based therapy https://t.co/JZmEya9uB2

[Bio&TechWebinar @BioTechWebinar]

$PFE $LLY successfully navigated a major Phase III study for the non-#opioid therapy among patients suffering from osteoarthritis #pharma https://t.co/scyPLbJW7h

[Bio&TechWebinar @BioTechWebinar]

Off-target #CRISPR–Cas9 deletions and complex rearrangements $EDIT $CRSP $NTLA https://t.co/JkAsGbYhyX

[Bio&TechWebinar @BioTechWebinar]

Reengineered base editors enable target modification in a wide range of mouse and human cell lines, and intestinal organoids with higher efficiency #CRISPR #biotech #IO https://t.co/L5YYrpJnon

[Bio&TechWebinar @BioTechWebinar]

New enzymes discovered. Improving the conversion of lignin into valuable products such as nylon, plastics, and chemicals #agrotech #biotech https://t.co/27h5levxc9

[Bio&TechWebinar @BioTechWebinar]

The Global Landscape of #Cancer Cell Therapy @CancerResearch $MRK $NVS $BMY #immunoOncology Updated on Mar 30, 2018 https://t.co/PL9nXP7bx8

[Bio&TechWebinar @BioTechWebinar]

$AZN AstraZeneca expands development deal with @Bicycle_tx #biotech #pharma https://t.co/jFG51e7iya via @BioPharmaDive

[Bio&TechWebinar @BioTechWebinar]

A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9. Using a #MachineLeaning approach, authors reveal that guide RNAs sharing specific 5-nucleotide seed sequences can produce strong fitness defects or even kill E. coli #CRISPR
https://t.co/CjD5049Aw1

[Bio&TechWebinar @BioTechWebinar]

Eli Lilly acquires small biotech for $1.6B to strengthen #cancer #ImmunoTherapy pipeline $LLY #pharma https://t.co/pJ3EvS48eM

[Bio&TechWebinar @BioTechWebinar]

A new form of DNA in our cells https://t.co/L2Bl5XBTA1

[Bio&TechWebinar @BioTechWebinar]

New #data protection regulations arriving next month have big implications for how patient data from #clinicaltrials, digital apps & #eHealth are used in research and to drive improvements in #EU’s healthcare systems #GDPR https://t.co/llI27sY9ex

[Bio&TechWebinar @BioTechWebinar]

#Servier acquires Shire’s #Oncology business to gain direct commercial access in the US $SHPG #cancer #pharma https://t.co/FwoLy3ETOk